Humanigen Inc (HGENQ)

[DonDonDonDon]

Don4, any “hopium” here?

It'll be interesting what the data says. The 78% of the LIVE-AIR trial that had a CRP<150mg/L had great data but the 25% of the the LIVE-AIR that had a CRP<41mg/L had 733% efficacy. Hopefully, the ACTIV data reconfirms this. So maybe there is still hope for moderate patients or very early severe patients. Obviously, that would require another trial. We'll have to see the data. CAR-T is still promising. My guess is that there will be a Big Pharma buyout which will at least help investors recoup some of their losses.